MarketLens

Has Arvinas Finally Turned the Corner with VEPPANU's FDA Approval

4 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Has Target Finally Turned the Corner with Digital Sales Growth

5 months ago

Has Trupanion Finally Turned the Corner on Profitability

6 months ago

Has Target Finally Turned the Corner After Its Q4 Earnings Beat

6 months ago

Has Impinj (PI) Stock Finally Turned the Corner

3 months ago

Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.

Revolution Medicines won FDA approval for daraxonrasib, a pancreatic adenocarcinoma pill touted as a 'miracle drug.' The approval opens a new treatment market, potentially boosting revenue and validat...

RVMD

Stock News•1 months ago

Can BMY's First CELMoD Approval Support Its Growth Strategy?

Bristol Myers won FDA accelerated approval for Zenbexus, the first CELMoD therapy, after data showed it doubled MRD-negative complete response rates, supporting its growth strategy.

BMY

Stock News•1 months ago

Arvinas Q2 Earnings Call Highlights

Arvinas is concentrating resources on early-stage oncology and neurology pipeline after H1 2026 milestones, including FDA approval of VEPPANU, the first PROTAC degrader, and an out-licensing deal with...

ARVN

Breaking News

Clinical Trials (Phase I, II, III)

Creator Economy

Crude Oil (WTI/Brent)

Top Headlines

View More →

Stock News•2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News•2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News•3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News•4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News•6 hours ago

Has Arvinas Finally Turned the Corner with VEPPANU's FDA Approval

Exclusive Content for Pro Members

Related Articles

Has Target Finally Turned the Corner with Digital Sales Growth

Has Trupanion Finally Turned the Corner on Profitability

Has Target Finally Turned the Corner After Its Q4 Earnings Beat

Has Impinj (PI) Stock Finally Turned the Corner

Category

You may also like

Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.

Can BMY's First CELMoD Approval Support Its Growth Strategy?

Arvinas Q2 Earnings Call Highlights

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Viral AI Dommer Tweet: Engineered Panic?

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today